Get 20% lifetime commission for referring investors to digrin.com
here.
Tonix Pharmaceuticals Holding Corp. ( TNXP) - Key Metrics
TNXP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.81 | -$2.44 | -$2.54 | -$2.57 |
| 2026Q1 | $0.50 | -$2.93 | -$3.09 | -$3.21 |
| 2025Q4 | $0.63 | -$5.51 | -$4.66 | -$4.88 |
| 2025Q3 | $0.37 | -$3.59 | -$3.42 | -$3.53 |
| 2025Q2 | $0.27 | -$3.86 | -$2.02 | -$2.37 |
TNXP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.31 |
| 2026Q1 | 0% | -1.17 |
| 2025Q4 | 0% | -0.91 |
| 2025Q3 | 0% | -1.68 |
| 2025Q2 | 0% | -2.33 |
TNXP
Price: $12.68
52 week price:
Payout Ratio Range:
Earnings Per Share: -13.09 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 943700
Ebitda: -5.8 millionMarket Capitalization: 218.0 million